Acceligen, a precision breeding company for food animals, is announcing publication in Antiviral Research of their work on breeding PRRSV-resistant pigs.
Porcine Reproductive and Respiratory Syndrome Virus, also known as PRRSV, is a virus that results in substantial economic harm to pig farms on a global scale, causing as extensive as $664 million in direct losses in the United States and reaching up to 1.5 billion Euros annually in Europe. Additionally, the animals may exhibit clinical signs inclusive of a phase of reduced appetite, fever, lethargy, depression, and possibly respiratory distress or vomiting.